Detalles de la búsqueda
1.
Etiology and outcomes of amputation in patients with peripheral artery disease in the EUCLID trial.
J Vasc Surg
; 75(2): 660-670.e3, 2022 02.
Artículo
Inglés
| MEDLINE | ID: mdl-34597783
2.
World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trial.
Vasc Med
; 27(1): 21-29, 2022 02.
Artículo
Inglés
| MEDLINE | ID: mdl-34516308
3.
Acute Limb Ischemia in Peripheral Artery Disease.
Circulation
; 140(7): 556-565, 2019 08 13.
Artículo
Inglés
| MEDLINE | ID: mdl-31238713
4.
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.
N Engl J Med
; 376(1): 32-40, 2017 01 05.
Artículo
Inglés
| MEDLINE | ID: mdl-27959717
5.
Major bleeding in patients with peripheral artery disease: Insights from the EUCLID trial.
Am Heart J
; 220: 51-58, 2020 02.
Artículo
Inglés
| MEDLINE | ID: mdl-31783279
6.
Stroke in Patients With Peripheral Artery Disease.
Stroke
; 50(6): 1356-1363, 2019 06.
Artículo
Inglés
| MEDLINE | ID: mdl-31092165
7.
Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial.
Vasc Med
; 24(5): 422-430, 2019 10.
Artículo
Inglés
| MEDLINE | ID: mdl-31339474
8.
A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative.
Circulation
; 135(25): 2534-2555, 2017 Jun 20.
Artículo
Inglés
| MEDLINE | ID: mdl-28630267
9.
Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease.
Circulation
; 135(3): 241-250, 2017 Jan 17.
Artículo
Inglés
| MEDLINE | ID: mdl-27840336
10.
Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial.
Eur J Vasc Endovasc Surg
; 55(1): 109-117, 2018 01.
Artículo
Inglés
| MEDLINE | ID: mdl-29273390
11.
Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
Vasc Med
; 23(6): 523-530, 2018 12.
Artículo
Inglés
| MEDLINE | ID: mdl-29992857
12.
Ticagrelor versus Clopidogrel in Peripheral Artery Disease.
N Engl J Med
; 376(15): 1488-9, 2017 04 13.
Artículo
Inglés
| MEDLINE | ID: mdl-28402763
13.
C-reactive protein, fibrinogen, and cardiovascular disease prediction.
N Engl J Med
; 367(14): 1310-20, 2012 Oct 04.
Artículo
Inglés
| MEDLINE | ID: mdl-23034020
14.
CYP2C19 status and risk of major adverse cardiovascular events in peripheral artery disease: Insights from the EUCLID Trial.
Am Heart J
; 229: 118-120, 2020 11.
Artículo
Inglés
| MEDLINE | ID: mdl-32950849
15.
Smoking, hypercholesterolaemia and hypertension as risk factors for cognitive impairment in older adults.
Age Ageing
; 42(3): 306-11, 2013 May.
Artículo
Inglés
| MEDLINE | ID: mdl-23302603
16.
Comparative analysis of genome-wide association studies signals for lipids, diabetes, and coronary heart disease: Cardiovascular Biomarker Genetics Collaboration.
Eur Heart J
; 33(3): 393-407, 2012 Feb.
Artículo
Inglés
| MEDLINE | ID: mdl-21804106
17.
Leptin levels and depressive symptoms in people with type 2 diabetes: the edinburgh type 2 diabetes study.
Psychosom Med
; 74(1): 39-45, 2012 Jan.
Artículo
Inglés
| MEDLINE | ID: mdl-22210236
18.
Lipid-related markers and cardiovascular disease prediction.
JAMA
; 307(23): 2499-506, 2012 Jun 20.
Artículo
Inglés
| MEDLINE | ID: mdl-22797450
19.
Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery Disease.
J Am Heart Assoc
; 11(11): e025504, 2022 06 07.
Artículo
Inglés
| MEDLINE | ID: mdl-35621222
20.
Understanding Study Drug Discontinuation Through EUCLID.
Front Cardiovasc Med
; 9: 947645, 2022.
Artículo
Inglés
| MEDLINE | ID: mdl-35928933